BIS
·NASDAQ
--
--(--)
--
--(--)
Key Stats
Assets Under Management
2.47MUSD
Fund Flows (1Y)
109.80KUSD
Dividend Yield
6.36%
Discount/Premium to NAV
0.02%
Shares Outstanding
261.10K
Expense Ratio
0.95%
About ProShares UltraShort NASDAQ Biotechnology
Issuer
ProShare Advisors
Brand
ProShares
Inception Date
Apr 7, 2010
Structure
Open-Ended Fund
Index Tracked
NASDAQ Biotechnology Index
Management Style
Passive
Dividend Treatment
Distributes
Distribution Tax Treatment
Ordinary income
Income Tax Type
Capital Gains
Max ST Capital Gains Rate
39.60%
Max LT Capital Gains Rate
20.00%
Primary Advisor
ProShare Advisors LLC
Distributor
SEI Investments Distribution Co.
BIS is one available fund that provides exposure to the biotech space — aiming for daily geared inverse (-2x) exposure to the NASDAQ Biotechnology Index (comprised of companies that are classified as either biotechnology or pharmaceutical). The fund expects to typically hold derivatives and money market instruments. Note: BIS is a tactical tool, it is not a buy-and-hold investment and should not be expected to provide index leverage returns greater than a one-day period.
Classification
Asset Class
Equity
Category
Sector
Focus
Health Care
Niche
Pharma, Biotech & Life Sciences
Strategy
Exchange-specific
Geography
U.S.
Weighting Scheme
Market Cap
Selection Criteria
NASDAQ-listed
Returns
1-Month | 3-Month | YTD | 1-Year | 3-Year | 5-Year | |
|---|---|---|---|---|---|---|
Price Performance | -4.74% | -30.70% | -47.45% | -49.28% | -50.78% | -58.47% |
NAV Total Return | -6.74% | -30.76% | -45.83% | -42.22% | -45.85% | -55.12% |
Ratings
No data is currently available
Ainvest’s AI-powered ETF Scoring Algorithm, built to help retail investors make smarter, data-driven decisions. Leveraging deep learning, reinforcement learning, and large language models, the algorithm scores ETFs across five key dimensions: Fund Flow, Momentum, Safety, Fundamentals, and Performance. Each factor is weighted by its correlation to future returns, resulting in a single, actionable score. Backtested over five years with consistently strong predictive accuracy. Ainvest brings institutional-grade artificial intelligence to everyday investors—transforming complexity into clarity with every score.
Holdings Analysis
Sector
No data is currently available
Asset
No data is currently available
Region
No data is currently available
Investment Style
No data is currently available
Top 10 Holdings
Symbol
Ratio
NASDAQ BIOTECHNOLOGY INDEX SWAP SOCIETE GENERALE
-33.39%
NASDAQ BIOTECHNOLOGY INDEX SWAP UBS AG
-35.90%
NASDAQ BIOTECHNOLOGY INDEX SWAP BANK OF AMERICA NA
-37.96%
NASDAQ BIOTECHNOLOGY INDEX SWAP CITIBANK NA
-41.85%
NASDAQ BIO INDEX SWAP BNP PARIBAS
-50.76%
Top 10 Weight -199.86%
5 Total Holdings
Dividends
Dividend Payout History
Declaration Date | Record Date | Payment Date | Amount |
|---|---|---|---|
| 2025-09-24 | 2025-09-24 | 2025-09-30 | 0.154 |
| 2025-06-25 | 2025-06-25 | 2025-07-01 | 0.108 |
| 2025-03-26 | 2025-03-26 | 2025-04-01 | 0.133 |
| 2024-12-23 | 2024-12-23 | 2024-12-31 | 0.206 |
| 2024-09-25 | 2024-09-25 | 2024-10-02 | 0.152 |
| 2024-06-26 | 2024-06-26 | 2024-07-03 | 0.161 |
| 2024-03-20 | 2024-03-21 | 2024-03-27 | 0.159 |
Show more
Premium/Discount Chart
Premium/Discount to NAV
Price
1M
Assets Under Management
Assets Under Management
1M
Fund Flows
Inflows
Outflows
1M
